Nasdaq Biotechnology Index Surges 6% as Industry Leaders Present at Boston Biotechnology Forum

Strategic Insights -

The Nasdaq Biotechnology Index saw a significant surge of over 6% on Friday, driven by the performance of top biotech companies such as Sepracor, Transkaryotic Therapeutics, and Ribozyme Pharmaceuticals. These companies were among the 15 presenting at the Boston Biotechnology Forum, held at the Seaport Hotel and online at informedinvestors.com.

Key Takeaways:

  • The Nasdaq Biotechnology Index surged over 6% on Friday, led by the performance of top biotech companies.
  • Sepracor, Transkaryotic Therapeutics, and Ribozyme Pharmaceuticals presented at the Boston Biotechnology Forum, which was held at the Seaport Hotel and online.
  • SG Cowen biotech analyst Bill Tanner keynoted the conference with an update on trends and developments in biotech, covering companies such as Genzyme Molecular Oncology and Genzyme Transgenics.
  • Fifteen companies presented at the forum, including ICN Pharmaceuticals, Photogen Technologies, Boston Life Sciences, EPIX Medical, Trega BioSciences, and Biopure.
  • Other presenting companies included OXiGENE, SafeScience, Repligen, Corvas International, and Isis Pharmaceuticals.

Statistics:

  • The Nasdaq Biotechnology Index surged 6% on Friday.
  • The Boston Biotechnology Forum was held at the Seaport Hotel and online at informedinvestors.com.
  • The conference featured 15 presenting companies, including Sepracor, Transkaryotic Therapeutics, and Ribozyme Pharmaceuticals.
  • SG Cowen biotech analyst Bill Tanner keynoted the conference with an update on trends and developments in biotech.
  • The event drew individual investors and featured direct access to the management of public biotechnology companies.

Sources:

  • PRNewsire, June 5
  • InformedInvestors.com